Inventor · disambiguated record
Carsten Linnemann
Also filed as: LINNEMANN CARSTEN
3 granted patents·5 pending applications·0 citations·filing 2015–2023
42Inventor score
Files withNEOGENE THERAPEUTICS B V3UNIV MUENCHEN TECH2AIMM THERAPEUTICS BV1BCRT HOLDING BV1KITE PHARMA EU B V1
Top patents by PatentIndex Score
8 records- 0167US2024036053A1T cell receptors and peptides derived by mutations for the treatment of cancerUNIV MUENCHEN TECH·Filed 2023·Application pending·0 cites
- 0251US11614449B2T cell receptors and peptides derived by mutations for the treatment of cancerUNIV MUENCHEN TECH·Filed 2016·Granted Mar 28, 2023·0 cites·18 claims
- 0336US12492386B2Methods to enrich genetically engineered T cellsNEOGENE THERAPEUTICS B V·Filed 2021·Granted Dec 9, 2025·0 cites·16 claims
- 0436US2022195006A1Peptide markers to track genetically engineered cellsNEOGENE THERAPEUTICS B V·Filed 2021·Application pending·0 cites
- 0534US10690658B2Means and methods for determining T cell recognitionAIMM THERAPEUTICS BV·Filed 2015·Granted Jun 23, 2020·0 cites·30 claims
- 0631US2021040558A1Method to isolate tcr genesNEOGENE THERAPEUTICS B V·Filed 2020·Application pending·0 cites
- 0730US2021155941A1Compositions and methods for making engineered t cellsKITE PHARMA EU B V·Filed 2019·Application pending·0 cites
- 0828US2017354681A1T cell-based immunotherapeuticsBCRT HOLDING BV·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Carsten Linnemann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →